Dont simply spread the rumour. I had also confirmed with RHB no such contra thing. This is very unlikely as this will restrict and affect the Healthcare sector growth. Let the market move itself.
The rumour on vaccine production , negative 17% of GDP and the recent contra ban on glove sector is purposely spread out to push down the price for IB or certain party to collect cheap for next wave 3 glove rally. Everything goes down fast will rise up fast as according to Newton law of action and reaction . Just hold tight for next rally take off..
No contra dealing. Stockbroker start selling first. then one by one they will announce this rule. Better run out from the door first before the stampede start.
Too expenaive to do research on Vaccine. It may not effective and fail. Why Russia dont want WHO to involve? Or follow medical ethic about drug research
Just buy when you feel it’s low..buy low sell high..that what makes profits...we just trust the fundamental....there are so many U turn story about vaccines...lots of rumours with no ending of its effectiveness about the vaccines...sometimes yes, sometimes no....bla.bla..bla....every news is just circulation around the corner to get the world survive..anyhow, we are living in the entertaining arena with no right or wrong or we will end up living in a bored world..
Gloves will continue be in high demand, glove makers will continue to have good profits for years. Hospitals, f&b , others will continue to use gloves as they do now cos this is the new “norm”.
Careplus maybe is a better return than Comfort in view of the huge increase in quartery earning and expension plan to double output to 8.8 billion eventually.
In a Facebook post, Health director-general Datuk Dr Noor Hisham Abdullah said the D614G mutation was first detected in July, and studies would likely reveal that any existing vaccine is ineffective against the mutation.
"It was found to be 10 times likely to infect other individuals and easier to spread by super spreader individuals.“
"Continue to take preventive measures and adhere to the standard operating procedures as stipulated, such as physical distancing, self-hygiene practices, and wear a mask when in public places," he said.
Explaining the matter, he said, the D614G mutation was discovered by scientists in July 2020 and it is likely to result in the study on existing vaccine to be incomplete or ineffective against the mutation.
Therefore, he advised the public to continue to apply preventive measures and public health control, which is to practise the prescribed standard operating procedures (SOP), like physical distancing, self-hygiene practices and to wear the face mask.
Moderna is an American biotechnology company focused on drug discovery, drug development, and vaccine technologies based exclusively on messenger RNA (mRNA). It is headquartered in Cambridge, Massachusetts.[4][5] The Moderna technology platform is to insert synthetic mRNA into living cells that would reprogram the cells to develop immune responses, rather than being created externally and injected as with conventional medicines. It is a novel technique abandoned by several large pharmaceutical and biotechnology companies that were unable to overcome the side effects of inserting RNA into cells.[6][7][8] As of May 2020, no mRNA drug has been approved for human use.[9][10]
Moderna has conducted mostly unsuccessful trials in traditional high-margin chronic therapeutic areas with AstraZeneca, and in orphan diseases with Alexion Pharmaceuticals. In 2014, Moderna moved to focus on lower-margin vaccines, given that an mRNA vaccine – efficacy issues aside – will always stimulate a level of antibody development in subjects.[5][8] The strategic change led industry experts, and Moderna employees, to question the financial viability of the company.[5][8]
In December 2018, Moderna became the largest biotech initial public offering (IPO) in history, raising US$600 million for 8% of its shares, implying an overall valuation of $7.5 billion, and with cumulative losses of $1.5 billion and equity raised of $3.2 billion, since inception.[5][11] As of May 2020, Moderna was valued at $30 billion, but none of its mRNA molecules had reached large clinical trials, and several had failed due to side-effects.
Frankly, Moderna is run by a bunch of ex-sales people, ex-IB, etc. Financially not in good shape. Slaoui, Moderna board member was appointed to Trump Operation Warp Speed. mRNA technology has never been proven and came with many side effects. Rossi, the founder and biologist, left. Executive sell news to jack up share price and dump big amount of stocks thereafter, etc............... With such credibility (or incredibility) and why would one believe Moderna wholeheartedly.
From my humble opinion, the biggest problem may be how we respond to Covid instead of Covid itself. There are growing numbers of people opt not to take the Covid vaccine even if a safe and effective one is available in 2021 or 2022 onwards especially if that is from China because of skepticism with the speed of the development, fake-news created by Putin, growing distrust against Trump, fanning conspiracy theory against China, etc. Without achieving herd immunity, Covid is here to stay.
The broker institute this no contra guideline to protect the glove traders & investors and remisier mah..if there is a crash alot of people will go bankrupt mah..!!
Better to let some air out 1st mah...!!
If the purchasers are so confident perhaps they should use their own cash to buy...why need to use remisier limit or margin and endanger much more people to the euphoria leh ?...!!
The brokers are right to institute pre emptive strike loh...!!
Posted by stockraider > Aug 17, 2020 12:33 AM | Report Abuse X
This stupid dali say gloves being a commodity they are sign of danger then why he do not allow the brokers to steer away from danger leh ??
I think people should be rational and allow the brokers to take preventive action mah...!!
Even though a vaccine may not result in lower demand for gloves, investors may sell their shares in anticipation that it’ll reduce the number of cases, RHB Research Institute analyst Alan Lim noted in an Aug. 13 report. Malaysia King
New IPO: Building management systems (BMS), solar thermal systems and energy-saving services provider, Solar District Cooling Bhd aims to list on the Ace Market!
MQ Trader 792 views | 5 d ago
0:17
New IPO: The onshore and offshore support services provider for the O&G industry, Steel Hawk Bhd aims to list on the Ace Market!
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
SuperPanda
11,431 posts
Posted by SuperPanda > 2020-08-16 08:16 | Report Abuse
if drop just buy, never know the bottom, it will rebound for sure bcoz profit will continue rise for the next few qtrs
if you out of capital and stuck at high side, then is was your wrong entry price
but if just enter below 4.5 and able to buy lower, the chance to make profit still big